CLINICAL_TRIALS
trial_result
· 2026-04-09
Clinical Trial Update: Letermovir for CMV Prevention After Lung Transplantation [Phase 2]
Summary
Phase 2 trial evaluating letermovir for CMV prevention after lung transplantation has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fernanda P Silveira, MD, MS | Conditions: Lung Transplant, CMV | Phase 2 | Status: COMPLETED | Results posted: 2026-04-09